Skip to main content

Stonarhini

Medically reviewed by Drugs.com. Last updated on Dec 10, 2019.

Dosage form: tablet
Ingredients: CHLORPHENIRAMINE MALEATE 2mg, PHENYLEPHRINE HYDROCHLORIDE 5mg
Labeler: Sato Pharmaceutical Co., Ltd.
NDC Code: 49873-109

Stonarhini v3

Active ingredients (In each tablet)        
Chlorpheniramine Maleate 2 mg    
Phenylephrine HCl 5 mg

Purpose
Chlorpheniramine Maleate    Antihistamine
Phenylephrine HCl        Nasal decongestant

Uses
Temporarily relieves these symptoms due to common cold, hay fever or other upper respiratory allergies (allergic rhinitis).
■ sneezing        ■ runny nose    ■ itchy, watery eyes
■ nasal congestion, stuffy nose        ■ itchy throat

Warnings

Enter section text here

Do not use this product
■ if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease) or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription contains an MAOI, ask a doctor or pharmacist before taking this priduct.

Ask a doctor before use if you have
■ a breathing problem such as emphysema or chronic bronchitis
■ glaucoma    ■ heart disease    ■ thyroid disease
■ diabetes    ■ high blood pressure
■difficulty in urination due to enlargement of the prostate

Ask a doctor or pharmacist before use
■ if you are taking sedatives or tranquilizers

When using this product
■ do not exceed recommended dosage.  If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor.
■ you may get drowsy.
■ may cause excitability, especially in children.
■ alcohol, sedatives and tranquilizers may increase the drowsiness effect.
■ avoid alcoholic beverages.
■ use caution when driving a motor vehicle or operating machinery.

Stop use and ask a doctor if
■ symptoms do not improve within seven days
■ symptoms are accompanied by fever

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.  Prompt attention is critical even if you do not notice any signs or symptoms.

Directions
adults and children 12 years and over:  2 tablets every 4 hours, not to exceed 12 tablets in 24 hours
children under 12 years of age:  ask a doctor

Inactive ingredients  aspartame, colloidal silicone dioxide, FD&C Red No. 40 aluminum Lake, flavor, hydroxypropyl cellulose, magnesium stearate, mannitol.

STONARHINI 
chlorpheniramine maleate, phenylephrine tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49873-109
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORPHENIRAMINE MALEATE (CHLORPHENIRAMINE) CHLORPHENIRAMINE MALEATE2 mg
PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE) PHENYLEPHRINE HYDROCHLORIDE5 mg
Inactive Ingredients
Ingredient NameStrength
ASPARTAME 
SILICON DIOXIDE 
FD&C RED NO. 40 
HYDROXYPROPYL CELLULOSE (TYPE EL) 
MAGNESIUM STEARATE 
MANNITOL 
ALUMINUM OXIDE 
Product Characteristics
Colorred (pale red) Scoreno score
ShapeROUNDSize10mm
FlavorMENTHOLImprint CodeS10
Contains    
Packaging
#Item CodePackage Description
1NDC:49873-109-014 BLISTER PACK in 1 CARTON
16 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34111/16/2001
Labeler - Sato Pharmaceutical Co., Ltd. (690575642)
Establishment
NameAddressID/FEIOperations
Sato Pharmaceutical Co., Ltd.715699133manufacture(49873-109), label(49873-109), pack(49873-109)

 
Sato Pharmaceutical Co., Ltd.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.